Literature DB >> 6606315

Cerebral NMR imaging: early results with a 0.12 T resistive system.

R A Zimmerman, L T Bilaniuk, H I Goldberg, R I Grossman, R S Levine, R Lynch, W Edelstein, P Bottomley, R Redington.   

Abstract

Over a 6-month period, 157 patients, 89 of whom had central nervous system tumors, were examined on a prototype 0.12 T resistive nuclear magnetic resonance (NMR) imaging unit. All of the patients had computed tomography (CT), which was used as a standard to which the NMR findings were compared. Studies were done primarily by saturation-recovery technique with short repetition times. The signal intensity with saturation-recovery technique did not allow differentiation among most tumor types. Location, extent, and morphology helped to some extent in attempts at differentiation. In the multiplanar mode, NMR compared favorably to CT with regard to lesion detection. Limited early experience suggests that NMR also may detect some lesions when the CT is negative and may detect additional lesions when one or more are present. The NMR examination was well tolerated by selected patients.

Entities:  

Mesh:

Year:  1983        PMID: 6606315     DOI: 10.2214/ajr.141.6.1187

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  10 in total

1.  The MR Cap: A single-sided MRI system designed for potential point-of-care limited field-of-view brain imaging.

Authors:  Patrick C McDaniel; Clarissa Zimmerman Cooley; Jason P Stockmann; Lawrence L Wald
Journal:  Magn Reson Med       Date:  2019-06-23       Impact factor: 4.668

2.  Nuclear magnetic resonance of the brain.

Authors:  G M Bydder
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

3.  Magnetic resonance imaging of colloid cysts of the third ventricle.

Authors:  N Roosen; D Gahlen; W Stork; E Neuen; W Wechsler; M Schirmer; E Lins; W J Bock
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

4.  Correlation of neuropathologic findings, computerized tomographic and high-resolution ultrasound scans of canine avian sarcoma virus-induced brain tumors.

Authors:  R H Britt; B E Lyons; D R Enzmann; E L Saxer; S H Bigner; D D Bigner
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

5.  Nuclear magnetic resonance imaging (NMR), (MRI), of brain stem tumours.

Authors:  S B Peterman; R E Steiner; G M Bydder; D J Thomas; J S Tobias; I R Young
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

6.  Resistive NMR of brain stem gliomas.

Authors:  R A Zimmerman; L T Bilaniuk; R Packer; L Sutton; L Samuel; M H Johnson; R I Grossman; H I Goldberg
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

7.  Cerebral NMR: diagnostic evaluation of brain tumors by partial saturation technique with resistive NMR.

Authors:  R A Zimmerman; L T Bilaniuk; R I Grossman; H I Goldberg; W Edelstein; P Bottomley; R W Redington
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

8.  MRI of subarachnoid dissemination of medulloblastoma.

Authors:  M Kochi; Y Mihara; A Takada; C Yatomi; M Morioka; S Yamashiro; S Yano; J Kuratsu; S Uemura; Y Ushio
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

9.  Application of contrast agents in CT and MRI (NMR): their potential in imaging of brain tumors.

Authors:  C Claussen; M Laniado; E Kazner; W Schörner; R Felix
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

10.  Malignancy and viability of intraparenchymal brain tumours: correlation between Gd-DTPA contrast MR images and proliferative potentials.

Authors:  Y Yoshii; Y Komatsu; T Yamada; A Hyodo; T Nose; E Kobayashi
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.